CompletedPhase 2NCT00694135
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis
Studying Anterior uveitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eyegate Pharmaceuticals, Inc.
- Principal Investigator
- C. Stephen Foster, MDMassachusetts Eye Research and Surgery Institution
- Intervention
- EGP-437 1.6 mA-min at 0.4 with EyeGate® II System(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 12-85 years · All sexes
- Timeline
- 2008 – 2009
Study locations (19)
- University of Miami, Miami, Florida, United States
- Emory Eye Center, Atlanta, Georgia, United States
- Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
- Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, United States
- Comprehensive Eye Care Ltd., Washington, Missouri, United States
- New York Eye & Ear Infirmary, New York, New York, United States
- Cleveland Eye Clinic, Cleveland, Ohio, United States
- Oregon Health Services University, Portland, Oregon, United States
- Pennsylvania College of Optometry, Elkins Park, Pennsylvania, United States
- Scheie Eye Institue, Philadelphia, Pennsylvania, United States
- Southern College of Optometry, Memphis, Tennessee, United States
- Texas Retina Associates, Dallas, Texas, United States
- Virginia Eye Consultants, Norfolk, Virginia, United States
- St. Johns Medical College and Hospital, Bangalore, Karnataka, India
- Vittala International Institute of Ophthalmology, Bangalore, Karnataka, India
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00694135 on ClinicalTrials.govOther trials for Anterior uveitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07285070Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisNovaliq GmbH
- RECRUITINGPHASE2NCT07552012A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIUShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07218770A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsRegeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT07262437Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine ProfilesUniversity of Milan
- ACTIVE NOT RECRUITINGPHASE3NCT06431373A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisPriovant Therapeutics, Inc.
- RECRUITINGNCT07065747Quantification & Classification of Inflammatory Cells in Uveitis Using OCTOregon Health and Science University
- RECRUITINGNCT06720376Observational Prospective Turkish Inception Cohort of Uveitis and SpondyloarthritisMarmara University
- RECRUITINGPHASE3NCT05486468The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentTexas Retina Associates